A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-Grade Gliomas or Brainstem Gliomas.

Trial Profile

A Phase 2 Study of Valproic Acid and Radiation, Followed by Maintenance Valproic Acid and Bevacizumab in Children With Newly Diagnosed High-Grade Gliomas or Brainstem Gliomas.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Valproic acid (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Nov 2016.
    • 20 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 13 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top